FindMyKOL
Clinical trialNCT05797662RecruitingPhase 2Interventional

A Study of Propranolol to Treat Kaposi Sarcoma

SponsorAIDS Malignancy ConsortiumEnrollment25Kaposi Sarcoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A clinical study of propranolol for the treatment of Kaposi Sarcoma in children and adults. This study will be an open-label single armed treatment trial that will test the effectiveness and the safety of treating Kaposi Sarcoma with propranolol.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Shane McAllister, Md, PhD

    University of Minnesota Medical School Department of Pediatrics

    Study Chair

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina
  • Fundación Huésped

    Buenos Aires, Argentina

    Recruiting
Brazil
  • Instituto Nacional de Câncer José de Alencar

    Rio de Janeiro, Brazil

    Not, yet, recruiting
  • Complexo Hospitalar Universitário Professor Edgard Santos

    Salvador, Brazil

    Not, yet, recruiting
Mexico
  • Instituto Nacional de Cancerologia

    Mexico City, Mexico

    Patricia Volkow, MD
    Not, yet, recruiting
Uganda
  • Uganda Cancer Institute

    Kampala, Uganda

    Jackson Orem, MD
    Not, yet, recruiting
Zimbabwe
  • University of Zimbabwe College of Health Sciences

    Harare, Zimbabwe

    Margaret Borok, MBChB (Hons) FRCP(UK)
    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2026
Primary completion
30 Sept 2028
Completion
31 Mar 2029
Last update posted
5 Oct 2026
Registered enrollment
25
Registry id
NCT05797662

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.